Category: Mergers & Acquisitions
Zimmer Holdings and Biomet find a buyer for the knee and elbow assets they pledged to divest to satisfy European anti-trust regulators about their pending $13 billion merger.
St. Jude Medical says it exercised the buyout option on its deal with Spinal Modulation and its Axium chronic pain device.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Feds slap former Acclarent execs with fraud charges; Zimmer extends deadline for $13B Biomet deal; Big data: IBM enlists Medtronic, J&J, Apple in major healthcare push
, Acclarent Inc.
, Ethicon Inc.
, Federal Trade Commission (FTC)
, Johnson & Johnson
, NxThera Inc.
U.S. anti-trust regulators approve the pending, $1.4 billion merger of Italy's Sorin Group and Cyberonics.
IBM unveils a major push to use 'Big Data' and its Watson supercomputer to drive healthcare research and personalized medicine, enlisting Medtronic, Johnson & Johnson and Apple to help.
Zimmer Holdings extends the deadline for its $13.4 billion merger with Biomet by 3 months as it waits on the U.S. Federal Trade Commission to approve the deal.
Federal prosecutors charge former Acclarent CEO William Facteau and ex-sales veep Patrick Fabian with fraud and conspiracy for allegedly marketing a sinus device for off-label uses.
Federal prosecutors last week leveled conspiracy and fraud charges against 2 former executives of Acclarent for an alleged off-label marketing scheme for the Relieva Stratus microflow spacer.